Harm reduction behaviors among polysubstance users who consume ecstasy: can they reduce the negative consequences? An exploratory study

References

• Allott, K., & Redman, J. (2006). Patterns of use and harm reduction practices of ecstasy users in Australia. Drug and Alcohol Dependence, 82, 168–176. doi:10.1016/j.drugalcdep.2005.09.009
   PubMed Web of Science ®Google Scholar
• Barratt, M. J., Kowalski, M., Maier, L. J., & Ritter, A. (2018). Global review of drug checking services operating in 2017. Drug Policy Modelling Program Bulletin No. 24. Sydney, Australia: National Drug and Alcohol Research Centre, UNSW Sydney.
   Google Scholar
• Belackova, V., Janikova, B., Vacek, J., Fidesova, H., & Miovsky, M. (2017). “It can’t happen to me”. Alcohol Drinkers on the 2012 Outbreak of Methanol Poisonings and the Subsequent Prohibition in the Czech Republic. Nordic Studies on Alcohol and Drugs, 34, 385–399. doi:10.1177/1455072517733597
   Web of Science ®Google Scholar
• Boeri, M. W., Sterk, C. E., Bahora, M., & Elifson, K. W. (2008). Poly-drug use among ecstasy users: Separate, synergistic, and indiscriminate patterns. Journal of Drug Issues, 38, 517–541. doi:10.1177/002204260803800207
   PubMed Web of Science ®Google Scholar
• Bravo, A. J., Anthenien, A. M., Prince, M. A., & Pearson, M. R. & Marijuana Outcomes Study Team. (2017). Marijuana protective behavioral strategies as a moderator of the effects of risk/protective factors on marijuana-related outcomes. Addictive Behaviors, 69, 14–21. doi:10.1016/j.addbeh.2017.01.007
   PubMed Web of Science ®Google Scholar
• Bravo, A. J., Prince, M. A., & Pearson, M. R. (2017). Can I use marijuana safely? An examination of distal antecedents, marijuana protective behavioral strategies, and marijuana outcomes. Journal of Studies on Alcohol and Drugs, 78, 203–212. doi:10.15288/jsad.2017.78.203
   PubMed Web of Science ®Google Scholar
• Brunt, T. M., Nagy, C., Bücheli, A., Martins, D., Ugarte, M., Beduwe, C., & Ventura Vilamala, M. (2017). Drug testing in Europe: Monitoring results of the Trans European Drug Information (TEDI) project. Drug Testing and Analysis, 9, 188–198. doi:10.1002/dta.1954
   PubMed Web of Science ®Google Scholar
• Carlson, R. G., Falck, R. S., McCaughan, J. A., & Siegal, H. A. (2004). MDMA/Ecstasy use among young people in Ohio: Perceived risk and barriers to intervention. Journal of Psychoactive Drugs, 36, 181–189. doi:10.1080/02791072.2004.10399728
   PubMed Web of Science ®Google Scholar
• Chiauzzi, E., DasMahapatra, P., Lobo, K., & Barratt, M. J. (2013). Participatory research with an online drug forum: A survey of user characteristics, information sharing, and harm reduction views. Substance Use & Misuse, 48, 661–670. doi:10.3109/10826084.2013.800117
   PubMed Web of Science ®Google Scholar
• Crean, R. D., Davis, S. A., & Taffe, M. A. (2007). Oral administration of (±) 3, 4-methylenedioxymethamphetamine and (+) methamphetamine alters temperature and activity in rhesus macaques. Pharmacology Biochemistry and Behavior, 87, 11–19. doi:10.1016/j.pbb.2007.03.015
   PubMed Web of Science ®Google Scholar
• Davis, A. K., & Rosenberg, H. (2017). Specific harm reduction strategies employed by 3, 4-methylenedioxymethamphetmine/ecstasy users in the United States and the United Kingdom. Drug Science, Policy and Law, 3, 1–8. doi:10.1177/2050324517711069
   Google Scholar
• Doumas, D. M., Miller, R., & Esp, S. (2017). Impulsive sensation seeking, binge drinking, and alcohol-related consequences: Do protective behavioral strategies help high risk adolescents? Addictive Behaviors, 64, 6–12. doi:10.1016/j.addbeh.2016.08.003
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2017). European Drug Report 2017: Trends and Developments. Luxembourg: Publications Office of the European Union.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2016). Recent changes in Europe’s MDMA/ecstasy market, EMCDDA Rapid Communication. Luxembourg: Publications Office of the European Union.
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. (2015). European Drug Report 2015: Trends and Developments. Luxembourg: Publications Office of the European Union.
   Google Scholar
• Fernández-Calderón, F., Cleland, C. M., & Palamar, J. J. (2018). Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances. Addictive Behaviors, 78, 85–93. doi:10.1016/j.addbeh.2017.11.004
   PubMed Web of Science ®Google Scholar
• Fernández-Calderón, F., Lozano Rojas, Ó. M., Acedos, I. B., Rojas Tejada, A. J., Giné, C. V., Moragues, E. V., & González-Saiz, F. (2012). Efectos asociados al policonsumo de drogas en fiestas rave [Effects associated with polydrug use at rave parties]. Health & Addictions, 12, 37–59.
   Google Scholar
• Fernández-Calderón, F., Lozano-Rojas, Ó. M., & Rojas-Tejada, A. J. (2013). Raves y consumo de drogas desde una perspectiva epidemiológica y psicosocial: Una revisión bibliográfica sistemática [Raves and drug use from an epidemiological and psychosocial perspective: a systematic bibliographic review]. Adicciones, 25, 269–279. doi:10.20882/adicciones.55
   PubMed Web of Science ®Google Scholar
• Fernández-Calderón, F., Lozano-Rojas, Ó., Rojas-Tejada, A., Bilbao-Acedos, I., Vidal-Giné, C., Vergara-Moragues, E., & González-Saiz, F. (2014). Harm reduction behaviors among young polysubstance users at raves. Substance Abuse, 35, 45–50. doi:10.1080/08897077.2013.792760
   PubMed Web of Science ®Google Scholar
• Fernández-Calderón, F., Lozano, Ó. M., Vidal, C., Ortega, J. G., Vergara, E., González-Sáiz, F., & Bilbao, I. (2011). Polysubstance use patterns in underground rave attenders: A cluster analysis. Journal of Drug Education, 41, 183–202. doi:10.2190/DE.41.2.d
   PubMed Web of Science ®Google Scholar
• Gamma, A., Jerome, L., Liechti, M. E., & Sumnall, H. R. (2005). Is ecstasy perceived to be safe? A critical survey. Drug and Alcohol Dependence, 77, 185–193. doi:10.1016/j.drugalcdep.2004.08.014
   PubMed Web of Science ®Google Scholar
• Greene, S. L., Dargan, P. I., O'connor, N., Jones, A. L., & Kerins, M. (2003). Multiple toxicity from 3, 4-methylenedioxymethamphetamine (“ecstasy”). The American Journal of Emergency Medicine, 21, 121–124. doi:10.1053/ajem.2003.50028
   PubMed Web of Science ®Google Scholar
• Grov, C., Kelly, B. C., & Parsons, J. T. (2009). Polydrug use among club-going young adults recruited through time-space sampling. Substance Use & Misuse, 44, 848–864. doi:10.1080/10826080802484702
   PubMed Web of Science ®Google Scholar
• Halpern, P., Moskovich, J., Avrahami, B., Bentur, Y., Soffer, D., & Peleg, K. (2010). Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions. Human & Experimental Toxicology, 30, 259–266. doi:10.1177/0960327110370984
   PubMed Web of Science ®Google Scholar
• Hunt, G., Evans, K., Moloney, M., & Bailey, N. (2009). Combining different substances in the dance scene: Enhancing pleasure, managing risk and timing effects. Journal of Drug Issues, 39, 495–522. doi:10.1177/002204260903900303
   PubMed Web of Science ®Google Scholar
• Jacinto, C., Duterte, M., Sales, P., & Murphy, S. (2008). Maximising the highs and minimising the lows: Harm reduction guidance within ecstasy distribution networks. International Journal of Drug Policy, 19, 393–400. doi:10.1016/j.drugpo.2007.09.003
   PubMed Web of Science ®Google Scholar
• Kalogeraki, S. (2011). On the benefits and constraints of the web-based illicit drug survey. International Journal of Interdisciplinary Social Sciences, 6, 239–252. doi: 10.18848/1833-1882/CGP/v06i05/52079
   Google Scholar
• Kelly, B. C. (2007). Club drug use and risk management among “Bridge and Tunnel” youth. Journal of Drug Issues, 37, 425–443. doi:10.1177/002204260703700210
   Web of Science ®Google Scholar
• Kelly, B. C. (2009). Mediating MDMA-related harm: Preloading and post-loading among ecstasy-using youth. Journal of Psychoactive Drugs, 41, 19–26. doi:10.1080/02791072.2009.10400671
   PubMed Web of Science ®Google Scholar
• Kelly, B. C., Parsons, J. T., & Wells, B. E. (2006). Prevalence and predictors of club drug use among club-going young adults in New York City. Journal of Urban Health, 83, 884–895. doi:10.1007/s11524-006-9057-2
   PubMed Web of Science ®Google Scholar
• Liechti, M. E., Kunz, I., & Kupferschmidt, H. (2005). Acute medical problems due to Ecstasy use. Case-series of emergency department visits. Swiss Medical Weekly, 135, 652–657. doi:2005/43/smw-11231
   PubMed Web of Science ®Google Scholar
• Lim, M. S., Hellard, M. E., Hocking, J. S., & Campbell, K. A. (2008). A cross-sectional survey of young people attending a music festival: Associations between drug use and musical preference. Drug and Alcohol Review, 27, 439–441. doi:10.1080/09595230802089719
   PubMed Web of Science ®Google Scholar
• Martens, M. P., Ferrier, A. G., Sheehy, M. J., Corbett, K., Anderson, D. A., & Simmons, A. (2005). Development of the protective behavioral strategies survey. Journal of Studies on Alcohol and Drugs, 66, 698–705. doi:10.15288/jsa.2005.66.698
   PubMed Web of Science ®Google Scholar
• Martens, M. P., Pederson, E. R., LaBrie, J. W., Ferrier, A. G., & Cimini, M. D. (2007). Measuring alcohol-related protective behavioral strategies among college students: Further examination of the protective behavioral strategies scale. Psychology of Addictive Behaviors, 21, 307–315. doi:10.1037/0893-164X.21.3.307
   PubMed Web of Science ®Google Scholar
• Matthews, A. J., & Bruno, R. (2010). An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers. Neuropsychobiology, 61, 215–222. doi:10.1159/000306592
   PubMed Web of Science ®Google Scholar
• Murphy, P. N., Wareing, M., & Fisk, J. E. (2006). Users' perceptions of the risks and effects of taking ecstasy (MDMA): A questionnaire study. Journal of Psychopharmacology, 20, 447–455. doi:10.1177/0269881106063270
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. (2018). MDMA (ecstasy/molly). National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services.
   Google Scholar
• National Institute on Drug Abuse. (2016). National survey on drug use and health: Trends in prevalence of various drug for ages 12 or older, ages 12 to 17, ages 18 to 25, and ages 26 or Older; 2013-2015. National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services.
   Google Scholar
• Palamar, J. J., Acosta, P., Ompad, D. C., & Cleland, C. M. (2017). Self-reported ecstasy/MDMA/“Molly” use in a sample of nightclub and dance festival attendees in New York City. Substance Use & Misuse, 52, 82–91. doi:10.1080/10826084.2016.1219373
   PubMed Web of Science ®Google Scholar
• Palamar, J. J., Salomone, A., Vincenti, M., & Cleland, C. M. (2016). Detection of “bath salts” and other novel psychoactive substances in hair samples of ecstasy/MDMA/“Molly” users. Drug and Alcohol Dependence, 161, 200–205. doi:10.1016/j.drugalcdep.2016.02.001
   PubMed Web of Science ®Google Scholar
• Panagopoulos, I., & Ricciardelli, L. A. (2005). Harm reduction and decision making among recreational ecstasy users. International Journal of Drug Policy, 16, 54–64. doi:10.1016/j.drugpo.2004.09.001
   Web of Science ®Google Scholar
• Parrot, A. C. (2004). MDMA (3, 4-Methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology, 50, 329–335. doi:10.1159/000080961
   PubMed Web of Science ®Google Scholar
• Parrot, A. C. (2015). Why all stimulant drugs are damaging to recreational users: An empirical overview and psychobiological explanation. Human Psychopharmacoly, 30, 213–224. doi:10.1002/hup.2468
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., & Young, L. (2014). Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes. Temperature, 1, 214–219. doi:10.4161/23328940.2014.977182
   PubMedGoogle Scholar
• Patel, M. M., Belson, M. G., Longwater, A. B., Olson, K. R., & Miller, M. A. (2005). Methylenedioxymethamphetamine (ecstasy)-related hyperthermia. The Journal of Emergency Medicine, 29, 451–454. doi:10.1016/j.jemermed.2005.05.007
   PubMed Web of Science ®Google Scholar
• Pearson, M. R. (2013). Use of alcohol protective behavioral strategies among college students: A critical review. Clinical Psychology Review, 33, 1025–1040. doi:10.1016/j.cpr.2013.08.006
   PubMed Web of Science ®Google Scholar
• Pearson, M. R., & Henson, J. M. (2013). Unplanned drinking and alcohol-related problems: A preliminary test of the model of unplanned drinking behavior. Psychology of Addictive Behaviors, 27, 584. doi:10.1037/a0030901
   PubMed Web of Science ®Google Scholar
• Pedersen, E. R., Hummer, J. F., Rinker, D. V., Traylor, Z. K., & Neighbors, C. (2016). Measuring protective behavioral strategies for marijuana use among young adults. Journal of Studies on Alcohol and Drugs, 77, 441–450. doi:10.15288/jsad.2016.77.441
   PubMed Web of Science ®Google Scholar
• Peters, G. J. Y., Kok, G., & Schaalma, H. P. (2008). Careers in ecstasy use: Do ecstasy users cease of their own accord? Implications for intervention development. BMC Public Health, 8, 376. doi:10.1186/1471-2458-8-376
   PubMed Web of Science ®Google Scholar
• Ramtekkar, U. P., Striley, C. W., & Cottler, L. B. (2011). Contextual profiles of young adult ecstasy users: A multisite study. Addictive Behaviors, 36, 190–196. doi:10.1016/j.addbeh.2010.10.004
   PubMed Web of Science ®Google Scholar
• Rigg, K. K. (2017). Motivations for using MDMA (ecstasy/molly) among African Americans: Implications for prevention and harm-reduction programs. Journal of Psychoactive Drugs, 49, 192–200. doi:10.1080/02791072.2017.1305518
   PubMed Web of Science ®Google Scholar
• Shelton, C. P., & Rosini, J. M. (2015). Multisystem organ failure and death resulting from ingestion of" molly"(3, 4-Methylenedioxymethamphetamine). Journal of Emergency Nursing, 41, 447–450. doi:10.1016/j.jen.2015.05.008
   PubMed Web of Science ®Google Scholar
• Skarupova, K. (2014). Computer-assisted and online data collection in general population surveys. Lisbon: European Monitoring Centre for Drugs and Drug Addiction,.
   Google Scholar
• Stough, C., Downey, L. A., King, R., Papafotiou, K., Swann, P., & Ogden, E. (2012). The acute effects of 3, 4-methylenedioxymethamphetamine and methamphetamine on driving: A simulator study. Accident Analysis & Prevention, 45, 493–497. doi:10.1016/j.aap.2011.08.017
   PubMed Web of Science ®Google Scholar
• Uosukainen, H., Tacke, U., & Winstock, A. R. (2015). Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. International Journal of Drug Policy, 26, 78–83. doi:10.1016/j.drugpo.2014.07.004
   PubMed Web of Science ®Google Scholar
• Van Havere, T., Vanderplasschen, W., Lammertyn, J., Broekaert, E., & Bellis, M. (2011). Drug use and nightlife: more than just dance music. Substance Abuse Treatment, Prevention, and Policy, 6, 18. doi:10.1186/1747-597X-6-18
   PubMed Web of Science ®Google Scholar
• van Heugten-Van der Kloet, D., Giesbrecht, T., van Wel, J., Bosker, W. M., Kuypers, K. P. C., Theunissen, E. L., … Ramaekers, J. G. (2015). MDMA, cannabis, and cocaine produce acute dissociative symptoms. Psychiatry Research, 228, 907–912. doi:10.1016/j.psychres.2015.04.028
   PubMed Web of Science ®Google Scholar
• Vevelstad, M., Øiestad, E. L., Middelkoop, G., Hasvold, I., Lilleng, P., Delaveris, G. J. M., … Arnestad, M. (2012). The PMMA epidemic in Norway: Comparison of fatal and non-fatal intoxications. Forensic Science International, 219, 151–157. doi:10.1016/j.forsciint.2011.12.014
   PubMed Web of Science ®Google Scholar
• Vidal Giné, C., Fernández-Calderón, F., & López Guerrero, J. (2016). Patterns of use, harm reduction strategies, and their relation to risk behavior and harm in recreational ketamine users. The American Journal of Drug and Alcohol Abuse, 42, 358–369. doi:10.3109/00952990.2016.1141211
   PubMed Web of Science ®Google Scholar
• Vidal Giné, C., Fornís Espinosa, I., & Ventura Vilamala, M. (2014). New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon? Drug Testing and Analysis, 6, 819–824. doi:10.1002/dta.1610
   PubMed Web of Science ®Google Scholar
• Vidal Giné, C., Ventura Vilamala, M., Fornís Espinosa, I., Gil Lladanosa, C., Calzada Álvarez, N., Fitó Fruitós, A., … de la Torre Fornell, R. (2016). Crystals and tablets in the Spanish ecstasy market 2000–2014: Are they the same or different in terms of purity and adulteration? Forensic Science International, 263, 164–168. doi:10.1016/j.forsciint.2016.04.016
   PubMed Web of Science ®Google Scholar
• White, B., Degenhardt, L., Breen, C., Bruno, R., Newman, J., & Proudfoot, P. (2006). Risk and benefit perceptions of party drug use. Addictive Behaviors, 31, 137–142. doi:10.1016/j.addbeh.2005.04.003
   PubMed Web of Science ®Google Scholar